ARWR
Price
$70.09
Change
-$0.73 (-1.03%)
Updated
Dec 12, 04:59 PM (EDT)
Capitalization
9.62B
60 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$22.10
Change
+$0.76 (+3.56%)
Updated
Dec 12, 04:59 PM (EDT)
Capitalization
14.84B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARWR vs ROIV

Header iconARWR vs ROIV Comparison
Open Charts ARWR vs ROIVBanner chart's image
Arrowhead Pharmaceuticals
Price$70.09
Change-$0.73 (-1.03%)
Volume$37.02K
Capitalization9.62B
Roivant Sciences
Price$22.10
Change+$0.76 (+3.56%)
Volume$446.84K
Capitalization14.84B
ARWR vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
ARWR vs. ROIV commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ARWR: $70.82 vs. ROIV: $21.34)
Brand notoriety: ARWR: Notable vs. ROIV: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 115% vs. ROIV: 226%
Market capitalization -- ARWR: $9.62B vs. ROIV: $14.84B
ARWR [@Biotechnology] is valued at $9.62B. ROIV’s [@Biotechnology] market capitalization is $14.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARWR and ROIV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 3 bullish TA indicator(s).

  • ARWR’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than ROIV.

Price Growth

ARWR (@Biotechnology) experienced а +9.53% price change this week, while ROIV (@Biotechnology) price change was +0.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

ARWR is expected to report earnings on Feb 10, 2026.

ROIV is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($14.8B) has a higher market cap than ARWR($9.62B). ARWR YTD gains are higher at: 276.702 vs. ROIV (80.389). ARWR has higher annual earnings (EBITDA): -52.51M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. ARWR (900M). ROIV has less debt than ARWR: ROIV (99.7M) vs ARWR (353M). ARWR has higher revenues than ROIV: ARWR (573M) vs ROIV (23.2M).
ARWRROIVARWR / ROIV
Capitalization9.62B14.8B65%
EBITDA-52.51M-1.18B4%
Gain YTD276.70280.389344%
P/E RatioN/A1.97-
Revenue573M23.2M2,470%
Total Cash900M4.5B20%
Total Debt353M99.7M354%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 9 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CCNR32.730.45
+1.38%
ALPS/CoreCommodity Natural Resources ETF
HYS94.990.08
+0.08%
PIMCO 0-5 Year High Yield Corp Bd ETF
MMCA21.810.01
+0.05%
NYLI MacKay California Muni Intmdt ETF
RFI10.95N/A
N/A
Cohen and Steers Total Return Realty Fund
SOFL22.73N/A
N/A
2x Daily Software Platform ETF